Cytokinetics sec filings

Author: zvrr

August undefined, 2024

WebMar 31, 2024 · CYTK Cytokinetics, Incorporated SEC Filings 8.71K followers $35.19 0.98 ( +2.86%) 4:00 PM 03/31/23 NASDAQ $USD Post-Market: $35.70 +0.51 (+1.45%) 5:56 … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision. ... SEC Filings. Annual Report and Proxy. Analyst Coverage. Investor FAQ. IR/Media Contacts. Corporate Governance. Information Request. Email Alerts.

SEC FILINGS Cytokinetics, Inc.

WebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics, Incorporated Common Stock (CYTK) SEC Filings … WebMar 27, 2024 · empowering muscle empowering lives. Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and … chronic stress health outcomes review hpa

SEC Filing Cytokinetics, Inc.

WebCytokinetics Inc. SEC filings breakout by MarketWatch. View the CYTK U.S. Securities and Exchange Commission reporting information. WebMar 3, 2024 · Fri., March 3, 2024 MarketBeat Logos Global Management LP cut its holdings in shares of Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 2.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). WebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. derivative assets and liabilities

Cytokinetics Announces Pricing of $450 Million Convertible

SEC Filing Cytokinetics, Inc.

WebMar 15, 2024 · Wed., March 15, 2024 MarketBeat Advisory Research Inc. lowered its holdings in Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 32.7% during the third quarter, according to its most recent filing with the … WebThis will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of Cytokinetics, Incorporated, a Delaware corporation, will be filed on behalf of … derivative assets - current แปลWebApr 12, 2024 · Oregon Public Employees Retirement Fund lifted its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 1.0% in the 4th quarter, … chronic stress hpa axis

"WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. " - Cytokinetics sec filings

Cytokinetics sec filings

CYTK SEC Filings - Cytokinetics, Inc. - Annual Report, Proxy …

WebApr 9, 2024 · Posted by Defense World Staff on Apr 9th, 2024 Inspire Investing LLC increased its stake in shares of Cytokinetics, Incorporated ( NASDAQ:CYTK – Get Rating) by 19.1% during the 4th quarter,... WebJan 8, 2024 · According to the 10-Q SEC Filing, Cytokinetics had cash, cash equivalents and investments of $668.9 million as of September 30, 2024. A big reason for the cash on hand was because of an offering ...

Did you know?

WebApr 13, 2024 · China Universal Asset Management Co. Ltd.’s holdings in Cytokinetics were worth $44,000 as of its most recent filing with the Securities & Exchange Commission. Several other large investors have also made changes to their positions in CYTK. Advisor Group Holdings Inc. lifted its position in shares of Cytokinetics by 14.9% in the first quarter. WebFeb 17, 2024 · Cytokinetics Inc CIK: 1061983 Ticker: CYTK GET DIRECTION ON YOUR INVESTMENTS Integrate SEC filing data within your own apps using our API Sign up Key Features Various SEC filing data available including balance sheets, cash flows and more Central Index Key (CIK) and ticker conversions for looking up companies

WebApr 10, 2024 · Cytokinetics To Participate In The 22nd Annual Needham Virtual Healthcare Conference. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ... WebOn February 2, 2024, Cytokinetics also issued a press release announcing Cytokinetics entry into the Royalty Agreement. A copy of the press release is filed as Exhibit 99.1 to …

WebApr 4, 2024 · Pinnacle Associates Ltd. owned approximately 0.30% of Cytokinetics worth $11,556,000 as of its most recent SEC filing. Want Diversified Upside in Biotechnology? … WebJul 1, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in …

WebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... SEC Filings. GlobeNewswire ...

WebApr 8, 2024 · Cytokinetics Inc (CYTK) SEC Filing DEF 14A Proxy Statement Report for the fiscal year ending Tuesday, May 10, 2024. Home. SEC Filings. ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), … chronic stress fractureWebFeb 24, 2024 · Cytokinetics Inc CIK: 1061983 Ticker: CYTK GET DIRECTION ON YOUR INVESTMENTS Integrate SEC filing data within your own apps using our API Sign up Key Features Various SEC filing data available including balance sheets, cash flows and more Central Index Key (CIK) and ticker conversions for looking up companies chronic stress effect on bodyWebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th … chronic stress disorder criteriaWebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in … chronic stress iapsWebMay 16, 2024 · CYTK SEC Filings - Cytokinetics, Inc. - Annual Report, Proxy Statement, Prospectus. ... SEC Filings All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), … derivative asylum for spouse chronic stress disorder symptomsWebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … derivative authority